多助剂个人新抗原疫苗在黑色素瘤中产生强大的免疫力
Eryn Blass1, Derin B Keskin2, Chloe R Tu3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
Cell
|July 11, 2025
概括
这项研究表明,将个性化新抗原疫苗与多种免疫辅助剂相结合,可增强黑色素瘤患者的T细胞反应. 这种多方面的方法提高了疫苗的免疫性,并重塑了瘤微环境以获得更好的结果.
科学领域:
- 癌症学
- 免疫学
- 疫苗开发
背景情况:
- 个性化新抗原疫苗对癌症治疗具有前景,但需要增强免疫性.
- 有效的T细胞培养和抗原可用性对于最大限度地提高疫苗疗效至关重要.
- 目前的策略往往需要改进以引起强大的抗瘤免疫反应.
研究的目的:
- 在黑色素瘤患者中评估新型合成长疫苗与多助剂策略的免疫性.
- 评估这种联合治疗对T细胞反应和瘤微环境的影响.
- 探索多端免疫辅助作用在提高新抗原疫苗疗效方面的潜力.
主要方法:
- 一组10名黑色素瘤患者接受了个性化的新抗原疫苗.
- 疫苗配方包括蒙塔尼德,多ICLC和局部伊皮利穆马布与全身尼沃卢马布.
- 分析了T细胞反应,T细胞受体 (TCR) 克隆型和瘤免疫细胞表型.
主要成果:
- 在9/9个完全接种疫苗的患者中,个性化疫苗诱导了对大多数新表位细胞的新活体T细胞反应.
- 在6/9名患者中观察到体外CD8+T细胞反应.
- 与单独抑制PD-1相比,接种疫苗产生了不同的循环和内TCR克隆类型.
- 这项研究表明疫苗接种后内T细胞的重建.
结论:
- 一种多方面的免疫辅助方法可以显著增强对个性化新抗原向疫苗的T细胞反应.
- 这种策略重塑了瘤的免疫微环境,
- 将个性化疫苗与多种辅助剂相结合是改善癌症疫苗免疫性的可行策略.
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Antigens Involved in Adaptive Immunity
690
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
690
Cytotoxic T Cells-mediated Immune Response
2.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.3K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


